Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: A placebo-controlled trial

Psychopharmacology

Volumn 214, Issue 4, 2011, Pages 933-939

  Mendelson, John E ^a   Coyle, Jeremy R ^a   Lopez, Juan Carlos ^a   Baggott, Matthew J ^a   Flower, Keith ^a   Everhart, E Thomas ^b   Munro, Thomas A ^c,d   Galloway, Gantt P ^a   Cohen, Bruce M ^c,d  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MCLEAN HOSPITAL   (United States)

Author keywords

Kappa opioid receptor; Salvia divinorum; Salvinorin A; Sublingual administration

Indexed keywords

PLACEBO; SALVINORIN A;

ADULT; ARTICLE; BIOAVAILABILITY; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG INTOXICATION; FEMALE; HUMAN; MALE; METABOLITE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SMOKING; URINE LEVEL;

ADMINISTRATION, SUBLINGUAL; ADULT; BIOLOGICAL AVAILABILITY; DITERPENES, CLERODANE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HALLUCINOGENS; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; RECEPTORS, OPIOID, KAPPA; SALVIA; YOUNG ADULT;

EID: 79953661182     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-2103-5     Document Type: Article

References (34)

1. Addy PH (2010) That deep internal voice: controlled administration of Salvia divinorum clinical psychology. Institute of Transpersonal Psychology, Palo Alto
2. Baggott MJ, Erowid E, Erowid F, Galloway GP, Mendelson J (2010) Use patterns and self-reported effects of Salvia divinorum in 500 users. Drug Alcohol Depend 111:250-256
3. Breton J, Huynh C, Raymond S, Labelle R, Bonnet N, Cohen D, Guilé J (2010) Prolonged hallucinations and dissociative self mutilation following use of Salvia divinorum in a bipolar adolescent girl. J Subs Use 15:113-117
4. Butelman ER, Harris TJ, Kreek MJ (2004) The plant-derived hallucinogen, salvinorin A, produces kappa-opioid agonist-like discriminative effects in rhesus monkeys. Psychopharmacology (Berl) 172:220-224 (Pubitemid 38388772)
5. Carlezon WA Jr, Beguin C, DiNieri JA, Baumann MH, Richards MR, Todtenkopf MS, Rothman RB, Ma Z, Lee DY, Cohen BM (2006) Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats. J Pharmacol Exp Ther 316:440-447 (Pubitemid 41832624)
6. Coyerly J, Peters L, Whittle E, Basketter DA (1998) Susceptibility to skin stinging, non-immunologic contact urticaria and acute skin irritation; is there a relationship? Wiley, New York, pp 90-95
7. Dittrich A (1998) The standardized psychometric assessment of altered states of consciousness (ASCs) in humans. Pharmacopsychiatry 31(Suppl 2):80-84
8. Fantegrossi WE, Kugle KM, Valdes LJ III, Koreeda M, Woods JH (2005) Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse. Behav Pharmacol 16:627-633 (Pubitemid 41682197)
9. González D, Riba J, Bouso JC, Gómez-Jarabo G, Barbanoj MJ (2006) Pattern of use and subjective effects of Salvia divinorum among recreational users. Drug Alcohol Depend 85:157-162 (Pubitemid 44468138)
10. Harris DS, Baggott M, Mendelson JH, Mendelson JE, Jones RT (2002) Subjective and hormonal effects of 3, 4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology (Berl) 162:396-405 (Pubitemid 35001902)
11. Katz MM, Waskow IE, Olsson J (1968) Characterizing the psychological state produced by LSD. J Abnorm Psychol 73:1-14
12. Keung WM, Lazo O, Kunze L, Vallee BL (1996) Potentiation of the bioavailability of daidzin by an extract of Radix puerariae. Proc Natl Acad Sci USA 93:4284-4288 (Pubitemid 26146731)
13. Munro TA (2006) The chemistry of Salvia divinorum chemistry. University of Melbourne, Melbourne
14. Munro TA, Rizzacasa MA (2003) Salvinorins D-F, new neoclerodane diterpenoids from Salvia divinorum, and an improved method for the isolation of salvinorin A. J Nat Prod 66:703-705 (Pubitemid 36617902)
15. Ortega A, Blount JF, Manchand PD (1982) Salvinorin, a new transneoclerodane diterpene from Salvia divinorum (Labiatae). J Chem Soc Perkins Trans 1:2505-2508
16. Ott J (1995) Ethnopharmacognosy and human pharmacology of Salvia divinorum and salvinorin A. Curare 18:103-129
17. Ott J (1996) Salvia divinorum Epling et Játiva (Foglie della Pastora/Leaves of the Sheperdess). Eleusis 4:31-39
18. Paulzen M, Grunder G (2008) Toxic psychosis after intake of the hallucinogen salvinorin A. J Clin Psychiatry 69:1501
19. Pavarin RM (2006) Substance use and related problems: a study on the abuse of recreational and not recreational drugs in Northern Italy. Ann Ist Super Sanità 42:477-484
20. Przekop P, Lee T (2009) Persistent psychosis associated with Salvia divinorum use. Am J Psychiatry 166:832
21. Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, Steinberg S, Ernsberger P, Rothman RB (2002) Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proc Natl Acad Sci USA 99:11934-11939 (Pubitemid 34994502)
22. Siebert DJ (1994) Salvia divinorum and salvinorin A: new pharmacologic findings. J Ethnopharmacol 43:53-56
23. Singh S (2007) Adolescent salvia substance abuse. Addiction 102:823-824
24. Snyder SH, Faillace LA, Weingartner H (1968) DOM (STP), a new hallucinogenic drug, and DOET: effects in normal subjects. Am J Psychiatry 125:113-120
25. Substance Abuse and Mental Health Services Administration (2006) The NSDUH report - use of specific hallucinogens. NSDUH, Rockville
26. Tsujikawa K, Kuwayama K, Miyaguchi H, Kanamori T, Iwata YT, Yoshida T, Inoue H (2008) Determination of salvinorin A and salvinorin B in Salvia divinorum-related products circulated in Japan. Forensic Sci Int 180:105-109
27. Turek I, Soskin R, Kurland AA (1974) Methylendedioxyamphetamine (MDA) subjective effects. J Psychedelic Drugs 6:7-13
28. Valdés LJ 3rd (1983) The pharmacognosy of Salvia divinorum Epling & Játiva-M: An investigation of Ska María Pastora. University of Michigan, (Ph.D. Thesis)
29. Valdés LJ 3rd, Butler WM, Hatfield GM, Paul AG, Koreeda M (1984) Divinorin A, a psychotropic terpenoid, and divinorin B, from the hallucinogenic Mexican mint, Salvia divinorum. J Org Chem 49:4716-4720 (Pubitemid 15155891)
30. Valdés LJ 3rd, Hatfield GM, Koreeda M, Paul AG (1987) Studies of Salvia divinorum (Lamiaceae), an hallucinogenic mint from the Sierra Mazateca in Oaxaca, Central Mexico. Econ Bot 41:283-291
31. Walsh SL, Strain EC, Abreu ME, Bigelow GE (2001) Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans. Psychopharmacology (Berl) 157:151-162 (Pubitemid 32802126)
32. Watson D, Clark LA, Tellegen A (1988) Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 54:1063-1070
33. Wolowich WR, Perkins AM, Cienki JJ (2006) Analysis of the psychoactive terpenoid salvinorin A content in five Salvia divinorum herbal products. Pharmacotherapy 26:1268-1272 (Pubitemid 44306887)
34. Zhah (2009) Lost in Jonathan Ott's footsteps: acetone tinctures of salvia divinorum. Entheogen Review 16:132-136